Skin cancer risk in BRCA1/2 mutation carriers
P V Gumaste1, L A Penn1, R M Cymerman1
1The Ronald O. Perelman Department of Dermatology, New York University School of Medicine, New York, NY, U.S.A.
Women with BRCA1/2 mutations face increased breast and ovarian cancer risks. Current research shows limited evidence linking these mutations to higher skin cancer risks, including melanoma.
Area of Science:
- Oncology
- Genetics
- Dermatology
Background:
- Women with BRCA1/2 mutations have significantly higher risks for breast and ovarian cancers.
- Concerns exist regarding their potential increased risk for other cancers, such as skin cancer.
- Existing research on BRCA1/2 mutations and skin cancer risk is limited and inconsistent.
Purpose of the Study:
- To review and synthesize current literature on the association between BRCA1/2 mutations and the risk of melanoma and nonmelanoma skin cancers.
- To evaluate the evidence supporting an increased risk of skin cancer in individuals with BRCA1/2 mutations.
Main Methods:
- Systematic literature review of studies investigating BRCA1/2 mutations and skin cancer risk.
- Analysis of findings regarding melanoma and nonmelanoma skin cancers in BRCA1/2 mutation carriers.
Main Results:
- No statistically significant increased risk of melanoma was found in BRCA1 mutation carriers.
- BRCA2 mutations have shown some association with melanoma, but evidence is inconsistent across studies.
- Conflicting results exist regarding the association between BRCA1/2 mutations and nonmelanoma skin cancers.
Conclusions:
- Insufficient evidence currently supports increased skin cancer surveillance for BRCA1/2 mutation carriers without other risk factors.
- Suspected BRCA1/2 mutation carriers should receive counseling on skin cancer risks.
- Yearly full skin examinations may be beneficial for suspected BRCA1/2 mutation carriers.
More Related Videos
08:53Identifying the Effects of BRCA1 Mutations on Homologous Recombination using Cells that Express Endogenous Wild-type BRCA1
Published on: February 17, 2011
13:04In Vivo and Ex Vivo Approaches to Study Ovarian Cancer Metastatic Colonization of Milky Spot Structures in Peritoneal Adipose
Published on: October 14, 2015
Related Concept Videos
Skin Cancer
Basal Cell Carcinoma (BCC): BCC is the most common type of skin cancer, accounting for about 80% of cases. It typically develops in...
Cancer Prevention
Some...
Cancer Prevention
Mutations
Chromosomal Alterations Are Large-Scale Mutations
While point mutations are changes in a single nucleotide in...
Mutations
Cancers Originate from Somatic Mutations in a Single Cell
